Optimization of Tolerability and Efficacy of Dual Amylin and Calcitonin Receptor Agonist, KBP-089, Through Dose Escalation and Combination With a GLP-1 Analogue
American Journal of Physiology - Endocrinology and Metabolism - United States
doi 10.1152/ajpendo.00419.2016
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2017
Authors
Publisher
American Physiological Society